Effects of glutamate uptake blockers on stimulus-induced field potentials in rat entorhinal cortex in vitro

Neuroscience Letters

Volumn 259, Issue 2, 1999, Pages 103-106

  Iserhot, Claudia ^a   Gloveli, Tengis ^a   Heinemann, Uwe ^a  

^a Univ Klin C   (Germany)

Author keywords

Dihydrokainate; Entorhinal cortex; Field potentials; In vitro; L trans 2,4 PDC; Rat

Indexed keywords

2,4 PYRROLIDINEDICARBOXYLIC ACID; CARRIER PROTEIN; DIHYDROKAINIC ACID; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID;

ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; ENTORHINAL CORTEX; HIPPOCAMPUS; NERVE CELL LESION; NERVE CELL MEMBRANE POTENTIAL; NERVE CELL NECROSIS; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPSE;

AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; CARRIER PROTEINS; DICARBOXYLIC ACIDS; ENTORHINAL CORTEX; EVOKED POTENTIALS; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; GLUTAMATES; PYRROLIDINES; RATS; RATS, WISTAR; SODIUM; SYMPORTERS;

EID: 0033534670     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00914-8     Document Type: Article

References (25)

1. A receptor: a molecular modeling approach. J. Neurosci. Res. 23:1989;129-135.
2. Arriza J.L., Eliasof S., Kavanaugh M.P., Amara S.G. Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chlorid conductance. Proc. Natl. Acad. Sci. USA. 94:1997;4155-4166.
3. Arriza J.L., Fairman W.A., Wadiche J.I., Murdoch G.H., Kavanaugh M.P., Amara S.G. Functional comparisons of three glutamate transporters subtypes cloned from human motor cortex. J. Neurosci. 14:1994;5559-5569.
4. Asztely F., Erdemli G., Kullmann D.M. Extrasynaptic glutamate spillover in the hippocampus: dependence on temperature and the role of active glutamate uptake. Neuron. 18:1997;281-293.
5. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. (Berlin). 82:1991;239-259.
6. Bridges R.J., Stanley M.S., Anderson M.W., Cotman C.W., Chamberlin A.R. Conformationally defined neurotransmitter analogs. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereomer. J. Med. Chem. 34:1991;717-725.
7. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
8. Collingridge G.L., Singer W. Excitatory amino acid receptors and synaptic plasticity. Trends Pharmacol. Sci. 11:1990;290-296.
9. Desai M.A., Burnett J.P., Mayne N.G., Schoepp D.D. Pharmacological characterization of desensitization in a human mGlu1α-expressing non-neuronal cell line co-transfected with a glutamate transporter. Br. J. Pharmacol. 118:1996;1558-1564.
10. Du F., Whetsell W.O., Abou-Khalil B., Blumenkopf B., Lothman E.W., Schwarcz R. Preferential loss in layer III of the entorhinal cortex in patients with temporal lobe epilepsy. Epilepsy Res. 16:1993;223-233.
11. Dumas T.C., Foster T.C. Development of metabotropic glutamate receptor-mediated synaptic inhibition. NeuroReport. 8:1997;2919-2924.
12. Ellison G. The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioural and anatomical models of dementias. Brain Res. Rev. 20:1995;250-267.
13. Engel, D., Schmitz, D., Gloveli, T., Frahm, C., Heinemann, U., and Draguhn, A., Laminar differences in GABA-uptake and GAT-1 expression in rat CA1, J. Physiol. (Lond.), (1998) In Press.
14. Gloveli T., Iserhot C., Schmitz D., Castrén E., Behr J., Heinemann U. Systemic administration of the phencyclidine compound MK-801 affects stimulus-induced field potentials selectively in layer III of rat medial entorhinal cortex. Neurosci. Lett. 221:1997;93-96.
15. Iwama T., Nagai Y., Tamura N., Harada S., Nagaoka A. A novel glutamate agonist, TAN-950 A, isolated from streptomycetes. Eur. J. Pharmacol. 197:1991;187-192.
16. Maki R., Robinson M.B., Dichter M.A. The glutamate uptake inhibitor L-Trans-pyrrolidine-2,4-dicarboxylate depresses excitatory synaptic transmission via a presynaptic mechanism in cultured hippocampal neurons. J. Neurosci. 14:1994;6754-6762.
17. Manahan-Vaughan D. Group 1 and 2 metabotropic glutamate receptors play differential roles in hippocampal long-term depression and long-term potentiation in freely moving rats. J. Neurosci. 17:1997;3303-3311.
18. Müller W., Misgeld U., Heinemann U. Carbachol effects on hippocampal neurons in vitro: dependence on the rate of rise of carbachol tissue concentration. Exp. Brain Res. 72:1988;287-298.
19. Ottersen O.P., Landsend A.S. Organization of glutamate receptors at the synapse. Eur. J. Neurosci. 9:1997;2219-2224.
20. +-dependent glutamate transport into acutely isolated Müller glial cells from guinea pig retina. Pflug. Arch. Eur. J. Physiol. 429:1994;140-142.
21. Reichelt W., Stabel-Burow J., Pannicke T., Weichert H., Heinemann U. The glutathione level of retinal Müller glial cells is dependent on the high-affinity sodium-dependent uptake of glutamate. Neuroscience. 77:1997;1213-1224.
22. Rothstein J.D., Jin L., Dykes-Hoberg M., Kuncl R.W. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. Natl. Acad. Sci. USA. 90:1993;6591-6595.
23. Scanziani M., Salin P.A., Vogt K.E., Malenka R.C., Nicoll R.A. Use-dependent increases in glutamate concentration activate presynaptic metabotropic glutamate receptors. Nature. 385:1997;630-634.
24. Stenkamp K., Heinemann U., Schmitz D. Dopamine suppresses stimulus-induced field potentials in layer III of rat medial entorhinal cortex. Neurosci. Lett. 255:1998;119-121.
25. Takahashi M., Sarantis M., Attwell D. Postsynaptic glutamate uptake in rat cerebellar Purkinje cells. J. Physiol. 497:1996;523-530.